Universal Net Receivables from 2010 to 2024

601231 Stock   15.71  0.36  2.35%   
Universal Scientific's Net Receivables is increasing over the years with slightly volatile fluctuation. Net Receivables is expected to dwindle to about 6.6 B. From 2010 to 2024 Universal Scientific Net Receivables quarterly data regression line had arithmetic mean of  6,425,300,006 and r-squared of  0.73. View All Fundamentals
 
Net Receivables  
First Reported
2008-12-31
Previous Quarter
9.2 B
Current Value
11 B
Quarterly Volatility
3.2 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Universal Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Universal Scientific's main balance sheet or income statement drivers, such as Interest Expense of 420.2 M, Selling General Administrative of 718.4 M or Total Revenue of 32.9 B, as well as many indicators such as . Universal financial statements analysis is a perfect complement when working with Universal Scientific Valuation or Volatility modules.
  
This module can also supplement various Universal Scientific Technical models . Check out the analysis of Universal Scientific Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Universal Stock

Universal Scientific financial ratios help investors to determine whether Universal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Universal with respect to the benefits of owning Universal Scientific security.